Abstract. Benzo(a)pyrene (BaP) stimulates lung cancer cells, promoting monocyte-derived dendritic cells to secrete soluble factors, including heparin binding-epidermal growth factor and C-X-C motif chemokine 5. The secretions from monocyte-derived dendritic cells stimulate the progression of lung cancer cells, including the migration and invasion of cells. To the best of our knowledge, these secretions remain unknown, and require additional study. The present study identified that treatment with BaP-H1395-tumor-associated dendritic cell-conditioned medium had the most marked effect on cell migration and invasion. This result may be associated with the female gender, stage 2 adenocarcinoma or mutation of the proto-oncogene B-Raf (BRAF), according to the cell line background. Laricitrin, a dietary flavonoid derivative present in grapes and red wine, suppresses certain factors and decreases the progression of lung cancer cells that are promoted by BaP in the lung cancer tumor microenvironment. The results of the present study suggest that prolonged exposure to BaP exacerbates lung cancer, particularly in female lung cancer patients with the BRAF mutation, but that laricitrin may ameliorate this effect.
Introduction
Lung cancer is the leading cause of cancer mortality worldwide and is also associated with a poor prognosis (1) . The tumor microenvironment has been demonstrated to be an important factor in cancer progression and drug resistance, as it may lead to dysregulated immune responses during tumor progression and the facilitation of tumor invasion (2) . Tumor-associated dendritic cells (TADCs) are important in the tumor microenvironment, as they secrete numerous factors that promote lung cancer growth, migration, invasion and epithelial-to-mesenchymal transition (3) . One factor, lung tumor-associated dendritic cell-derived resistin, has been indicated to promote cancer progression (4) . Other lung TADC factors that have synergistic effects on cancer progression include heparin-binding epidermal growth factor-like growth factor and chemokine CXCL5 (5) .
Benzo(a)pyrene (BaP) is a carcinogenic polycyclic aromatic hydrocarbon that has been associated with lung cancer. BaP is found in cigarettes, food and automobile exhausts (6) . BaP causes DNA adduct formation, which is the initiating event in carcinogenesis (7) . BaP has also been demonstrated to promote A549 cell migration and invasion by upregulating Twist (8) .
Flavonols are usually present in glycosidic forms and are synthesized in grape skin; therefore, they are also present in red wine (9) . Flavonols are a subclass of flavonoid that have antioxidant properties and have a potential role in the prevention of cardiovascular disease (10) . Flavonoids have also been demonstrated to have the potential to induce colorectal cancer cell apoptosis via the mitochondrial-mediated pathway (11) . Flavonoids also suppress the growth of H460 and A549 cells by inducing cell cycle arrest in the S and G2/M phases. Additionally, flavonoids also induce apoptosis in H460 and (12) . Laricitrin is a flavonol that is present predominantly as 3-glucoside (13) . The present study investigated the association between laricitrin and the BaP-associated lung cancer tumor microenvironment. 6 cells/100 mm dish) were treated with or without BaP (Sigma-Aldrich) at a concentration of 10 µM for 6 h. Subsequent to washing and culturing for 24 h, the CM of BaP-treated H1395, H1975, H2087 and HCC2935 cells (BaP-H1395-CM, BaP-H1975-CM, BaP-H2087-CM and BaP-HCC2935-CM, respectively) were harvested (Fig. 1A) .
Materials and methods

Chemicals
Isolation of CD14
+ monocytes and differentiation of monocyte-derived dendritic cells (mdDCs). Monocytes were obtained from peripheral blood mononuclear cells (PBMCs) obtained from healthy, consenting donors. Mononuclear cells were isolated from the blood using the Ficoll-Hypaque gradient (GE Healthcare Life Sciences, Little Chalfont, UK). CD14 + monocytes were purified using MACS MicroBeads CD14 + monoclonal antibody-conjugated magnetic beads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), according to the manufacturer's protocol. mdDCs were generated by culturing CD14 + monocytes in RPMI-1640 containing FBS and 20 ng/ml granulocyte macrophage-colony-stimulating factor (GM-CSF) and 10 ng/ml interleukin-4 (IL-4) (R&D Systems, Inc., Minneapolis, MN, USA) for 5 days. The medium was replaced with fresh medium containing GM-CSF and IL-4 on day 3. For the maturation of DCs, immature mdDCs were stimulated with lipopolysaccharide (LPS; 100 ng/ml; Sigma-Aldrich) subsequent to priming with interferon-γ (IFN-γ; EMD Millipore, Billerica, MA, USA) for 3 h. At the end of treatment in the two assays, the cells were stained with CyQuant GR dye (part of the QCM 24-well Cell Migration and Invasion Assay kit; EMD Millipore) in cell lysis buffer for 15 min at room temperature. The fluorescence of the migrated and invaded cells was read using a fluorescence plate reader (FLx800; Bio-Tek Instruments, Inc., Winooski, VT, USA) at excitation/emission wavelengths of 485/520 nm.
Laricitrin treatments. The protocol for assessing the effect of laricitrin involved the aforementioned isolation, proliferation, migration and invasion steps, with a slight modification. Briefly, the mdDCs, H1395-TADCs, Bap-H1395-TADCs, HCC2935-TADCs Statistical analysis. The data were expressed as the mean ± standard error. Statistical comparisons were made using one-way analysis of variance with post-hoc Tukey's test. Significant differences between the means of the two test groups were analyzed by Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
Results
Subsequent to exposure to BaP, lung cancer cells affect mdDCs, which then contributes to lung cancer progression by increasing cancer cell migration and invasion.
To investigate the effect of BaP on tumor progression in the lung cancer tumor microenvironment, the effects of BaP-H1395-TADC-CM, BaP-H1975-TADC-CM, BaP-H2087-TADC-CM and BaP-HCC2935-CM on the proliferation, migration and invasion of lung cancer cells were examined. A concentration of 20% of the aforementioned media increased the proliferation of lung cancer cells. This effect is similar to that in H1395, H1975, H2087 or HCC2935 cells treated with 10 µM BaP. Notably, the proliferation effect was not increased when these cells were treated with BaP (Fig. 2) . Compared with H1395-TADC-CM, BaP-H1395-TADC-CM did not enhance H1395 cell proliferation ( Fig. 2A) . Compared with H1975-TADC-CM, BaP-H1975-TADC-CM did not enhance H1975 cell proliferation (Fig. 2B) . Compared with H2087-TADC-CM, BaP-H2087-TADC-CM did not enhance H2087 cell proliferation (Fig. 2C) . Compared with HCC2935-TADC-CM, BaP-HCC2935-TADC-CM did not enhance HCC2935 cell proliferation (Fig. 2D ). However, a 20% concentration of H1395-TADC-CM, H1975-TADC-CM, H2087-TADC-CM or HCC2935-TADC-CM was indicated to induce lung cancer cell migration and invasion, and a 20% concentration of the aforementioned media may additionally increase this effect (Figs. 3 and 4) . It was found that BaP-H1395-TADC-CM enhanced H1395 cell migration and invasion compared with H1395-TADC-CM (Figs. 3A and 4A ). BaP-H1975-TADC-CM enhanced H1975 (Figs. 3B and 4B ). BaP-H2087-TADC-CM enhanced H2087 cell migration and invasion compared with H2087-TADC-CM (Figs. 3C and 4C ). In addition, BaP-HCC2935-TADC-CM enhanced HCC2935 cell migration and invasion compared with HCC2935-TADC-CM (Figs. 3D and 4D) . Therefore, the proliferation effect may not be increased; however, the migration and invasion effects increase in cancer cells with BaP-treatment. Comparing each TADC-CM with mdDC-CM, HCC2935-TADC-CM revealed that had the most marked effect on cancer proliferation, migration and invasion. Comparison of the BaP-treated TADC-CMs with each TADC-CM revealed that BaP-H1395-TADC-CM demonstrated the most marked effect on promoting cancer cell migration and invasion.
Laricitrin suppresses BaP-induced lung tumor-associated monocyte-derived dendritic cell-increased cancer progression in the lung cancer tumor microenvironment.
Compared with cell lines not treated with BaP, HCC2935-TADC-CM demonstrated the most marked effect on the proliferation, migration and invasion of lung cancer cells. However, BaP-H1395-TADC-CM exerted the strongest effect on the migration and invasion of lung cancer cells (Figs. 3 and 4) . Therefore, the HCC2935 and H1395 cell lines were selected as models for developing antidotes against BaP-associated cancer aggravation in the lung cancer tumor microenvironment.
The effect of laricitrin, a dietary flavonoid derivative present in grapes and red wine, on BaP-induced cancer progression was then assessed. The results in Fig. 5 revealed that, although laricitrin did not inhibit the proliferation of (Fig. 5A) , it did inhibit the lung cancer cell migration induced by H1395-TADC-CM and HCC2935-TADC-CM (Fig. 5B) . In addition, laricitrin suppressed the lung cancer cell invasion that was induced by BaP-H1395-TADC-CM and BaP-HCC2935-TADC-CM (Fig. 5C ).
Discussion
Lung cancer is currently the leading cause of cancer-associated mortality worldwide. BaP has been demonstrated to induce lung cancer development; however, the role of BaP in the lung cancer tumor microenvironment remains unclear. Exposure to BaP may not be completely avoided; however, numerous factors may affect the deleterious effects of BaP, such as gender, epidermal growth factor receptor (EGFR) mutation and proto-oncogene B-Raf (BRAF) mutation. The present study investigated the association between certain factors and the effect of BaP on lung cancer progression. Table I shows the background of the cell lines used in the present study (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . A previous study using CD-1 mice indicated that female mice are more susceptible to the carcinogenic effects of BaP compared with males (29) . Therefore, being female may increase the risk of BaP-induced lung cancer. BRAF mutation is another risk factor for non-small cell lung cancer and adenocarcinoma of the lungs (30) . A previous study performed using BRAF V600E mutant mice revealed that the expression of the BRAF mutation leads to adenocarcinoma development and is essential for tumor maintenance (31) . EGFR mutation is also a risk factor for adenocarcinoma, as EGFR maintains the malignant phenotype of lung cancer cells (32) . Comparison between invasive adenocarcinoma and preinvasive adenocarcinoma tissue samples indicated that there is an increased frequency of EGFR mutation in invasive adenocarcinoma, and an increased frequency of the BRAF mutation in preinvasive adenocarcinoma (33) . Although EGFR mutation is not an independent prognostic factor (34), BRAF mutation is associated with poor disease-free survival and poor overall survival rates (35) . Female gender, late-stage lung cancer and EGFR and BRAF mutations are risk factors for BaP-induced lung cancer progression. In addition, BRAF mutation is a greater risk factor compared with EGFR mutation.
Comparison between the BaP-treated TADC-CMs and each TADC-CM indicated that BaP-H1395-TADC-CM had the most marked effect on promoting cancer cell migration and invasion, with an increase of 1.5 fold, compared with the other cell lines, which increased ~1.2 fold. This result may be due to H1395 cells possessing the greatest number of risk factors, as they were obtained from a female smoker with BRAF mutation (14) (15) (16) (17) (18) . Comparison between each TADC-CM and mdDC-CM indicated that HCC2935-TADC-CM had the most marked effect on the proliferation, migration and invasion of cancer cells. The HCC2935 cell line was established from the pleural effusion cells of an adenocarcinoma patient (18) (19) (20) (21) (22) . Lung cancer with malignant pleural effusion indicates terminal-stage disease (36) . Therefore, HCC2935 cells may possess increased potential for metastasis compared with other cell lines.
To the best of our knowledge, the present study is the first to investigate the association between BaP and lung tumor-associated monocyte-derived dendritic cell-increased cancer aggravation in various cell lines. The present study has two novel findings: i) That lung tumor-associated monocyte-derived dendritic cells, following exposure to BaP, contribute to cancer progression by increasing cancer cell migration and invasion; and ii) that laricitrin, a dietary flavonoid derivative present in grapes and red wine, reverses BaP-mediated lung cancer aggravation (Fig. 6) . BaP exacerbates cancer cell migration and invasion in the lung cancer tumor microenvironment. Laricitrin may reverse this effect. Notably, the H1395 cell line demonstrated the most marked enhancement of migration and invasion following exposure to BaP-H1395-TADC-CM, and possessed the greatest number of risk factors. This finding suggests that BaP may be able to induce cancer cell migration and invasion without promoting proliferation in patients with the highest number of risk factors. Therefore, patients with lung cancer that possess numerous risk factors and are in contact with BaP may demonstrate an increased possibility of metastasis and invasion. In conclusion, the development of a drug with the potential for treating BaP-induced cancer progression is vitally important.
